市場調查報告書
商品編碼
1401954
2030 年生物電子市場預測:按類型、產品類型、應用、最終用戶和地區分類的全球分析Bioelectronics Market Forecasts to 2030 - Global Analysis By Type, Product Type, Application, End User and By Geography |
根據Stratistics MRC預測,2023年全球生物電子市場規模將達87億美元,預計2030年將達到209億美元,預測期內複合年成長率為13.3%。
生物電子學是醫學的一個分支,研究生物科學在電機和電子工程的應用。生物電子學以電機工程原理為基礎,具有廣泛的應用,包括醫學、生物研究和生理健康。生物電子學的一個主要目標是與軟組織和移動組織相互作用。生物電子感測器用於檢測特定的生物標記、病原體和化學物質。
據心臟基金會稱,2011 年僅美國就有 787,000 人死於心臟病和其他心血管疾病。此外,根據國際糖尿病聯盟(IDF)的數據,2015年約有4.15億人患有糖尿病。
植入式裝置的使用增加
推動生物電子市場成長的關鍵因素之一是植入式設備的使用不斷增加。植入式生物電子設備為從神經系統疾病到慢性疼痛管理等各種醫療狀況提供有針對性和持久的治療性介入。此外,植入式生物電子學的好處正在得到患者和醫療保健專業人員的廣泛認可,特別是在傳統藥物干預措施不適合的情況下。此外,由於人口高齡化和慢性疾病的增加,植入式生物電子設備持續成長。
生物相容性和安全問題
生物電子市場受到生物相容性和安全問題的高度限制,阻礙了市場的擴張。將電子設備與生物系統整合時,必須格外小心,以避免對生物組織產生不利影響或損壞。此外,確保生物電子設備與人體的兼容性至關重要,因為這些設備變得越來越複雜並用於各種應用,例如神經介面和植入式醫療設備。實現生物相容性需要解決組織反應、發炎以及對周圍解剖結構的潛在長期影響等問題。
技術進步
技術發展是推動生物電子市場進入新的創造性和高效領域的關鍵因素。小型化過程允許創建小型非侵入性設備,從而提高患者的舒適度和依從性。提高感測器效能可提高生物電子學的靈敏度和準確性,從而實現更精確的監測和診斷。此外,改進的連接功能有利於即時資料傳輸,促進衛生系統整合,並支援遠端患者監控。不斷發展的技術確保了由不斷創新驅動的動態生物電子市場,塑造醫療保健服務和患者治療結果的未來。
電源和能源效率
電源和能源效率的挑戰成為生物電子市場的關鍵抑制因素。許多生物電子設備,尤其是植入式設備,需要可靠且持久的電源。然而,此類設備的電力儲存空間通常有限,使得確保持續高效的能源供應變得特別複雜。此外,對小型化的需求使得在不影響設備功能或壽命的情況下整合滿足生物電子應用的能源需求的電源系統變得更加困難。
COVID-19 大流行對生物電子市場產生了重大影響,影響了短期中斷和長期趨勢。封鎖和社會疏離措施擾亂了研發活動,減緩了該行業的創新。然而,這種流行病也凸顯了遠端患者監護和遠端醫療解決方案的重要性,促使對實現此類功能的生物電子設備的需求增加。
電化學生物感測器領域預計將在預測期內成為最大的領域
電化學生物感測器領域預計將佔據最大佔有率。基於細胞的電化學生物感測器為生物、醫學、化學、製藥和環境研究做出了重要貢獻。這些生物感測器透過使用全細胞和電化學換能器作為識別元件來擴展生物感測和生命科學研究。電化學生物感測器具有許多優點,包括更高的靈敏度、卓越的精度和準確度、易於使用的介面、實惠的價格、低樣品要求、易於整合到攜帶式平台、低功耗和連接複用功能等優勢。
生物電子醫療領域預計在預測期內複合年成長率最高
預計生物電子醫療產業在預測期內將出現良好成長。這是因為對個人化醫療的需求不斷成長,以及新型生物電子學研發活動的快速增加正在影響該行業的收益成長。這個快速發展的領域使用客製化的電脈衝來識別和管理各種病症,包括慢性疼痛、抗治療性癲癇和心律不整。醫學生物電子學,特別是電極技術,被認為是植入設備技術進步最有前景的領域之一,也具有歷史意義。
由於生物電子學在各個醫療領域的應用不斷增加,北美在預測期內佔據了最大的市場佔有率。此外,大量研發設施的存在,醫療專業人員、臨床醫生和患者擴大採用精密和先進的產品,以及久坐生活方式帶來的嚴重疾病數量的增加(精神障礙、癌症、心血管疾病病例的增加)疾病(如心血管疾病)可能會促進北美地區的收益成長。
預計歐洲在預測期內將出現盈利成長。歐洲擁有強大的醫療基礎設施和對先進醫療技術優勢的高度認知。此外,歐洲對健康和保健意識的不斷增強,加上慢性病盛行率的上升,正在推動對包括生物電子學在內的先進醫療解決方案的需求。歐洲處於生物電子市場創新的前沿,匯集最尖端科技,創造患者照護和治療的新範例。
According to Stratistics MRC, the Global Bioelectronics Market is accounted for $8.7 billion in 2023 and is expected to reach $20.9 billion by 2030 growing at a CAGR of 13.3% during the forecast period. Bioelectronics is a branch of medical science that deals with the application of ideologies of biological sciences in electrical/electronic engineering. Bioelectronics is based on the principles of electrical engineering and has wide applications in medicine, biological research, and physiological health. The main aim of bioelectronics is to interact with soft and motile tissues. Bio electronic sensors are employed for detecting specific biological markers, pathogens, or chemical substances.
According to the Heart Foundation, in 2011, heart and other cardiovascular diseases led to 787 thousand fatalities in the U.S. alone. Moreover, as per International Diabetic Federation (IDF) around 415 million people suffered from diabetes in 2015.
Rising use of implantable devices
One major factor driving the bioelectronics market's growth is the increasing use of implantable devices. Implantable bio electronic devices offer targeted and durable therapeutic interventions for a variety of medical conditions, ranging from neurological disorders to chronic pain management. Additionally, the perks of implantable bioelectronics are becoming more widely recognized by patients and healthcare professionals, especially in situations where conventional pharmaceutical interventions might not be suitable. Moreover, implantable bio electronic devices are growing due to the aging population and the rise in chronic diseases that go along with it.
Biocompatibility and safety issues
The bioelectronics market is severely constrained by biocompatibility and safety issues, which is impeding its expansion. When electronic devices are integrated with biological systems, great care must be taken to make sure they do not cause negative reactions or damage living tissues. Moreover, ensuring bio electronic devices are compatible with the human body is critical because these devices are becoming more complex and are used in a variety of applications, such as neural interfaces and implantable medical devices. Achieving biocompatibility involves addressing issues such as tissue response, inflammation, and potential long-term effects on surrounding biological structures.
Technological advancements
Technological developments are a key factor driving the bioelectronics market into new creative and efficient spheres. The process of miniaturization makes it possible to create small, non-intrusive devices that improve patient comfort and compliance. Improved sensor performance increases bioelectronics' sensitivity and precision, allowing for more precise monitoring and diagnosis. Furthermore, improved connectivity features also make it easier to transfer data in real-time, which makes it possible to integrate healthcare systems easily and support remote patient monitoring. The ever-evolving nature of technology ensures a dynamic bioelectronics market where continuous innovation is a driving force, shaping the future of healthcare delivery and patient outcomes.
Power supply and energy efficiency
The challenge of power supply and energy efficiency stands out as a significant restraint in the bioelectronics market. A dependable and long-lasting power source is necessary for many bio-electronic devices, especially those that are implantable. However, these devices frequently have limited space for power storage, so ensuring a continuous and efficient energy supply becomes especially complex. Additionally, the need for miniaturization adds an extra layer of difficulty in incorporating power systems that meet the energy demands of bio electronic applications without compromising the device's functionality or longevity.
The COVID-19 pandemic has exerted a significant impact on the bioelectronics market, influencing both short-term disruptions and long-term trends. Lockdowns and social distancing measures hindered research and development activities, slowing down innovation in the field. However, the pandemic also underscored the critical importance of remote patient monitoring and telehealth solutions, driving increased demand for bio electronic devices that enable such capabilities.
The electrochemical biosensor segment is expected to be the largest during the forecast period
The electrochemical biosensor segment is estimated to hold the largest share. The cell-based electrochemical biosensor offers an important contribution to biology, medicine, chemistry, pharmacology, and environmental research. These biosensors expand bio sensing and life science research by using whole cells and electrochemical transducers as recognition elements. Electrochemical biosensors have a number of benefits, including increased sensitivity, excellent precision and accuracy, an easy-to-use interface, affordability, a low sample requirement, ease of integration into portable platforms, low power consumption, and the ability to multiplex.
The bio-electronic medicine segment is expected to have the highest CAGR during the forecast period
The bio-electronic medicine segment is anticipated to have lucrative growth during the forecast period, due to the growing demand for personalized or customizable medicine and rapidly increasing R&D activities for the development of novel bioelectronics are influencing the revenue growth of this segment. This quickly developing field uses customized electrical impulses to identify and manage a variety of conditions, including chronic pain, treatment-resistant epilepsy, and arrhythmias. Medical bioelectronics, especially electrode technology, is considered one of the most promising fields for advancement in implanted device technology and has historical significance.
North America commanded the largest market share during the extrapolated period owing to increase the applications of bioelectronics in various healthcare domains. Additionally, the presence of a sizable number of R&D facilities, an increase in the adoption of refined and advanced products by healthcare professionals, clinicians, and patients, and an increase in the cases of several serious diseases (such as psychological disorders, cancer, and cardiovascular diseases) brought on by sedentary lifestyles are likely to boost revenue growth in the North American region.
Europe is expected to witness profitable growth over the projection period. Europe boasts a robust healthcare infrastructure, coupled with a high level of awareness regarding the benefits of advanced medical technologies. Additionally, the European population's increasing awareness of health and wellness, coupled with a rising prevalence of chronic diseases, propels the demand for advanced medical solutions, including bioelectronics. Europe is at the forefront of innovation in the bioelectronics market, creating a new paradigm for patient care and treatment by bringing together cutting-edge technologies.
Some of the key players in the Bioelectronics Market include Boston Scientific Corp., F. Hoffmann-La Roche A.G., Abbott Laboratories, Inc., Cochlear Ltd., Bioelectronics Corp., Danaher Corp., Cala Health, Inc., Nova Biomedical Corp., Micronit Microtechnologies B.V., Siemens AG, Medtronic PLA, OmniVision Technologies, Inc., Universal Biosensors Pty. Ltd., Bayer AG and Sensirion AG.
In March 2023, Bayer collaborates with Microsoft to unveil new cloud-based enterprise solutions, advancing innovation and transparency in the agri-food industry.
In March 2023, Abbott partners with Medinbox to improve connections and information sharing between physicians in electrophysiology labs worldwide.